Quinine sulfate 300mg tabs/PAC-100

General Description:
Quinine Sulfate 300mg film coated tablets, containing 82.6% quinine anhydrous base, bottle pack of 100

Technical Specifications:
Each film coated tablet contains Quinine Sulfate 300mg, equivalent to 82.6% quinine anhydrous base

The salt used and the % of Quinine base in the salt must be specified on the label and pack insert.
It must be specified whether the dosage strength displayed is that of the salt of the base.

Therapeutic class:
Quinine is an alkaloid derived from the Cinchona tree.

Standard shelf life:
5 years (60 months)

Guidelines for use:
For more details, please click the links listed below:

WHO Guidelines for the treatment of Malaria http://www.who.int/malaria/publications/atoz/9789241549127/en


WHO Model List of Essential Medicines for adults and/or children


WHO Model Formulary


or your regional/national guidelines

Indications
Treatment of multiple drug resistant malaria, often as second line treatment; treatment of severe malaria caused by Plasmodium falciparum.
Can be considered as alternative therapy for chloroquine sensitive strains of P falciparum, P. ovale, P. malariae and P. vivax; by mouth (oral)

Dosage
Suggested dosing is based on WHO guidelines, please click link below:

WHO Guidelines for treatment of malaria, second edition



Storage:
Store at temperatures not exceeding 25 degrees Celsius (77 degrees Fahrenheit); excursions permitted to 15-30 degrees Celsius (59-86°Fahrenheit).
Store in original packaging
Keep out of the reach of children
Protect from light and moisture

Dispensing instructions:
To be taken after meals.
Repeat dose if vomiting occurs within one hour of taking the last dose.

Regulatory Status
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines


List of USFDA approved and tentatively approved items


Component of a kit
S9901005 - IEHK2011,kit,basic unit,malaria

Note: the IEHK2011,kit,basic unit,malaria is only supplied via air shipment.